Theoverallgoalofthisproposalistoprovidekeyinsightsintotheexcessaccumulationof smoothmusclecells(SMCs)thatcharacterizesmultiplevascularpathologies.TheGreiflabandother groupshaveshownthatpathologicalremodelinginducedinatherosclerosisorhypoxiainvolvesrobust clonalexpansionofrareSMCprogenitors.Herein,weproposetostudythemacrophage-mediated regulationofSMCprogenitorsinvasculardisease.Werecentlyidentifiedapoolofsmoothmuscle progenitorsthatwehavetermed?primed?cells(asinprimedtomuscularize),locatedateach muscular-unmusculararterioleborderinthelungandwithauniquemolecularsignatureexpressing SMCmarkersandtheundifferentiatedmesenchymemarkerplatelet-derivedgrowthfactorreceptor (PDGFR)-?.Withhypoxiaexposure,oneoftheseprogenitorsclonallyexpandsgivingrisetothevast majorityofSMCsthatcoatthenormallyunmuscularizeddistalarteriole.Macrophagesaccumulatein thelungwithhypoxiabuttheirroleintheensuingvascularremodelingisnotwellunderstand.Our initialstudiesdemonstratethatmacrophagesinthehypoxiclunghaveenhancedlevelsofhypoxia- induciblefactor(HIF)-?andtheligandplatelet-derivedgrowthfactor(PDGF)-B.Furthermore,we demonstratethatdeletionofPdgfbwithtwoindependentknock-inmice(LysM-CreorCsf1r-CreER), whichinducerecombinationinmacrophages/monocytes,attenuateshypoxia-induceddistalarteriole muscularization.Additionally,macrophagedepletioninhibitspathologicalvascularremodeling.We hypothesizethatlungmacrophageHIF-?isrequiredcellautonomouslyforhypoxia-inducedPDGF-B expression,andmacrophage-derivedPDGF-BiscriticalforprimedSMCproliferationand dedifferentiationinpulmonaryvascularremodeling.Totestthishypothesis,wewillutilizetransgenic mice,primedcellsandmacrophagesubpopulationsisolatedfromthemouselungaswellashuman monocytesandpulmonaryarterySMCs.Wehavecarefullyassembledagroupoftop-notch collaboratorswithdiverseexpertise,rangingfrommacrophagesinvascularandlungdiseasesto bioengineeringofnanoparticles,whichwillfacilitatebringingtheproposaltofruition.Thisproposal specificallyaimsto:1)elucidatecellularmechanismsunderlyingmacrophage-derivedPDGF-B inductionofdistalpulmonaryarteriolemuscularizationinhypoxia;?2)assessroleofspecific macrophagepopulationsinhypoxia/PDGFB-inducedpulmonaryvascularremodeling;?and3) determinetheroleofmacrophageHIF-?inhypoxia-inducedPDGF-BexpressionandinPDGF-B- mediateddistalmuscularization.Insum,theproposedstudieswillyieldfundamentalinsightsintothe roleofmacrophage-SMCprogenitorinteractionsinvasculardiseaseandtherebysuggestnovel therapeuticstrategies.

Public Health Relevance

Remodelingofbloodvesselsisacriticalcomponentofdiversevasculardiseases. Recently,weidentifiedspecializedprogenitorsinthewallsofvesselsinthelungthatplaya criticalroleinthispathologicalremodeling.Theproposedstudieswillcharacterizetheregulation oftheseprogenitorsbyinflammatorycellsinthecontextofvasculardiseaseandthus,facilitate thedevelopmentofnoveltherapeuticstrategies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL142674-02
Application #
9769127
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Lin, Sara
Project Start
2018-09-01
Project End
2020-06-30
Budget Start
2019-09-01
Budget End
2020-06-30
Support Year
2
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520